Skip to content

Merck & Co., Inc.

MRK

CIK 0000310158

← back to feed
Revenue (TTM)
$64.9B
+1.3% YoY Q1 Apr 2026
Net Income (TTM)
$11.05B
+6.6% YoY Q1 Apr 2026
EPS Diluted (TTM)
$4.37
+8.0% YoY Q1 Apr 2026
Gross Margin
76.8%
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
17.0%
Q1 Apr 2026
Free Cash Flow (TTM)
$6.66B
Q1 Apr 2026
Cash
$5.33B
Q1 Apr 2026
Total Debt
$49.12B
Q1 Apr 2026
Shares Outstanding
2.47B sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings